Quarterly report pursuant to Section 13 or 15(d)

Investments in Non-Marketable Securities - Carrying Value and Fair Value of Securities (Details)

v3.22.2
Investments in Non-Marketable Securities - Carrying Value and Fair Value of Securities (Details) - USD ($)
$ in Thousands
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Total non-marketable equity securities      
Marketable Securities [Line Items]      
Investment in non-marketable equity securities $ 19,302   $ 14,002
Molecular Assemblies, Inc. (“MAI”)      
Marketable Securities [Line Items]      
Investments and other noncurrent assets, with related party 12,713   12,713
seqWell      
Marketable Securities [Line Items]      
Investment in non-marketable equity securities 5,000 $ 5,000 0
Arzeda      
Marketable Securities [Line Items]      
Investment in non-marketable equity securities 1,289   1,289
Other investments in non-marketable equity securities      
Marketable Securities [Line Items]      
Investment in non-marketable equity securities $ 300   $ 0